Skip to content
  • Reports
  • Podcast
  • Log In

Now covering the global biotech industry!
Read More
Topics
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • CRISPR
  • CAR-T
  • Covid-19
  • Microbiome
  • mRNA technology
  • Gene therapy
  • Log In
Now covering the global biotech industry!
Read More

Home » What’s new » Valneva

Valneva

ADVERTISEMENT
News and Trends

Valneva’s Inactivated Covid-19 Vaccine Aces Phase III Trial

Last week, the French vaccine maker Valneva announced promising phase III trial results of its…

By Victor Kotsev
26/10/2021 - 5 minutes
News and Trends

Chikungunya Vaccine First to Succeed in Phase III Trial 

In a significant step in the fight against tropical disease, the mosquito-borne viral disease chikungunya…

By Victor Kotsev
19/08/2021 - 3 minutes
News and Trends

The Top European Biotech Investment Rounds in May

Last month saw huge biotech investment rounds dedicated to Covid-19 vaccines in Europe, including IPOs…

By Jonathan Smith
10/06/2021 - 4 minutes
News and Trends

Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal

The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…

By Karen O’Hanlon Cohrt
07/05/2020 - 4 minutes
News and Trends

Update: Single-Shot Vaccine for Chikungunya Lasts for a Year in Phase I

Update (18/11/2019): French biotech Valneva has revealed additional phase I results concerning its experimental chikungunya…

By Jonathan Smith
18/11/2019 - 3 minutes
Interview

Overcoming Clinical Setbacks to Fight Insect-Borne Diseases

Sometimes things don’t go your way in the biotech industry. The CEO of Valneva, Thomas…

By Jonathan Smith
04/09/2019 - 9 minutes
More News!

Phase I Gives Hope for First Zika Vaccine

Results from a Phase I trial showed promising safety and efficacy of a potential first…

By Jonathan Smith
20/11/2018 - 2 minutes
News and Trends

French Biotech Puts a New Lyme Disease Vaccine on the Horizon

There is currently no vaccine for the fast-growing disease in the US, & treatments cost…

By Evelyn Warner
12/12/2016 - 2 minutes
News and Trends

[Update] Valneva’s duck stem cells attract two new Vaccine-deals

French Valneva continues to sign license agreements for its duck derived stem cell line that produces…

By Philip Hemme
28/08/2015 - 2 minutes
News and Trends

Valneva penetrates Chinese Market thanks to a license agreement

A few months ago, the article "An Anglo-French Partnership To Cure Hepatitis B" related Valneva…

By Joachim Eeckhout
18/03/2015 - 2 minutes
News and Trends

An Anglo-French Partnership To Cure Hepatitis B

European biotechnology company Valneva and UK company Immune Targeting Systems (ITS) announced that they have…

By Lourdes Riquelme
31/01/2015 - 2 minutes
footer logo

Labiotech.eu is the leading digital media covering the global biotech industry.

Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Hope you’ll enjoy reading our stories!

  • About us
  • Inside Labiotech
  • Join Us
  • Advertise
  • Contact
  • Editorial Calendar
  • Site Map
  • Linkedin
  • Twitter
  • Youtube
  • RSS Feed
Made with in Berlin. Labiotech UG, All Rights Reserved -
  • Imprint
  • Privacy Policy

Browse Topics

Search for a topic, country or company name by using the search box

    Popular topics:


    CRISPR mRNA technology CAR-T HIV Cell therapy Diabetes Microbiome Startups Gene therapy Synthetic biology
    Labiotech.eu
    Log In Newsletter

    Topics

    • Gene Therapy
    • CRISPR
    • CAR-T
    • Covid-19
    • Microbiome
    • Diabetes
    • Cancer

    Sections

    • News and Trends
    • In Depth
    • Best in Biotech
    • Opinion
    • Interview
    • Infographics
    Show All Topics

    For Members

    • Expert Advice
    • Reports
    • Startup Scout

    More

    • About us
    • Inside Labiotech
    • Join Us
    • Advertise
    • Contact
    • Podcast